-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Market Analysis] Recently, Guangdong Huizhou Medical Insurance Bureau issued an announcement that it intends to terminate the service agreement with 109 medical insurance designated retail pharmacies including Zhengkang Pharmacy in Zhongkai High-tech Zone, Huizhou Cit.
Judging from the list, most of the 109 pharmacies are single pharmacies, and there are active and passive reasons for withdrawing from medical insuranc.
In addition to Huizhou, Guangdong, some pharmacies in many places have recently applied to terminate the medical insurance fixed-point service, and many small and medium-sized pharmacies have voluntarily withdrawn from medical insuranc.
For example, in mid-April this year, the Dongguan Municipal Medical Insurance Bureau of Guangdong Province issued a notice to terminate the medical insurance agreement of seven retail pharmacie.
The notice shows that the reason for the seven retail pharmacies to apply for the cancellation of the medical insurance agreement is due to business adjustmen.
In early April, Guanyun County, Lianyungang City, Jiangsu Province issued the "Announcement of Units Proposed to Release the Agreement Management of Designated Medical Institutions of Basic Medical Insurance.
The materials have been accepted, and the management of the agreement of the designated medical institutions for basic medical insurance is planned to be lifte.
Earlier in January, Songyuan City, Jilin Province, Baofeng County, Pingdingshan City, Henan Province and other places also issued relevant announcements, and a total of 15 retail pharmacies took the initiative to apply for withdrawal from the designated medical insuranc.
It can be seen that a large number of small and medium-sized pharmacies are taking the initiative to withdraw from medical insuranc.
While a number of enterprises are withdrawing, the strong chains are actively deployin.
Recently, the Guangzhou Municipal Medical Insurance Bureau announced the announcement of the evaluation of "dual-channel" designated retail pharmacie.
From the list, among the 30 designated retail pharmacies selected, there are many subsidiaries such as Sinopharm Holding, China Resources Pharmaceutical, Dashenlin, Neptune Star, and Ali Healt.
Large chain pharmac.
The current "dual-channel" policy is being accelerate.
Currently, more than 10 provinces have released the list of "dual-channel" managed drugs, which brings opportunities to the retail pharmacy industry and can better meet the requirements of informatization, drug management, and medical insurance fund supervisio.
Leading companies responded positively to this wave of dividend.
Among them, Dashenlin will add 115 new stores in 2021 to obtain the qualification of dual-channel overall planning, covering 7 provinces and 31 prefecture-level citie.
As of January 21, 2022, a total of 119 stores have obtained dual-channel overall planning qualifications, covering a wide range, involving 1 municipality and 47 prefecture-level cities in 11 provinces including Hunan, Guangxi, Zhejiang, Henan, and Shandon.
In addition to being shortlisted for "dual-channel" designated retail pharmacies, leading chain companies are accelerating their staking, striving to enter the "Era of Ten Thousand Stores.
Among them, the common people have achieved this goal on June 26 this year, becoming the first private listed pharmacy chain enterprise in China with the number of stores exceeding "10,000 stores.
As of the end of March this year, the common people had 8,612 stores, that is to say, in less than three months, the number of new stores for the common people was as high as 1,388.According to the development momentum, the other three leading chain enterprises including Dashenlin, Yifeng Pharmacy, and Yixintang are also expected to achieve the goal of 10,000 stores this yea.
As of the end of March this year, Yifeng Pharmacy had 8,225 stores (a net increase of 416 stores in the first quarter), 8,469 Dashenlin stores (a net increase of 276 stores in the first quarter), and 8,809 Yixintang direct chain stores (a net increase of 276 stores in the first quarter.
Net addition of 249 stores in the quarter.
In general, at present, leading companies are accelerating mergers and acquisitions and expansion, and small and medium-sized pharmacies are accelerating their exi.
The integration pressure of the entire pharmaceutical retail market is intensifying, and the industry concentration will continue to increas.
The "Guiding Opinions on Promoting the High-Quality Development of the Drug Circulation Industry During the "14th Five-Year Plan" Period" pointed out that by 2025, 5-10 specialized pharmacies with a value of over 50 billion yuan will be cultivated, and the annual sales of the top 100 drug retail enterprises will account for The total retail market is more than 65%; the drug retail chain rate is close to 70.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyon.
Judging from the list, most of the 109 pharmacies are single pharmacies, and there are active and passive reasons for withdrawing from medical insuranc.
In addition to Huizhou, Guangdong, some pharmacies in many places have recently applied to terminate the medical insurance fixed-point service, and many small and medium-sized pharmacies have voluntarily withdrawn from medical insuranc.
For example, in mid-April this year, the Dongguan Municipal Medical Insurance Bureau of Guangdong Province issued a notice to terminate the medical insurance agreement of seven retail pharmacie.
The notice shows that the reason for the seven retail pharmacies to apply for the cancellation of the medical insurance agreement is due to business adjustmen.
In early April, Guanyun County, Lianyungang City, Jiangsu Province issued the "Announcement of Units Proposed to Release the Agreement Management of Designated Medical Institutions of Basic Medical Insurance.
The materials have been accepted, and the management of the agreement of the designated medical institutions for basic medical insurance is planned to be lifte.
Earlier in January, Songyuan City, Jilin Province, Baofeng County, Pingdingshan City, Henan Province and other places also issued relevant announcements, and a total of 15 retail pharmacies took the initiative to apply for withdrawal from the designated medical insuranc.
It can be seen that a large number of small and medium-sized pharmacies are taking the initiative to withdraw from medical insuranc.
While a number of enterprises are withdrawing, the strong chains are actively deployin.
Recently, the Guangzhou Municipal Medical Insurance Bureau announced the announcement of the evaluation of "dual-channel" designated retail pharmacie.
From the list, among the 30 designated retail pharmacies selected, there are many subsidiaries such as Sinopharm Holding, China Resources Pharmaceutical, Dashenlin, Neptune Star, and Ali Healt.
Large chain pharmac.
The current "dual-channel" policy is being accelerate.
Currently, more than 10 provinces have released the list of "dual-channel" managed drugs, which brings opportunities to the retail pharmacy industry and can better meet the requirements of informatization, drug management, and medical insurance fund supervisio.
Leading companies responded positively to this wave of dividend.
Among them, Dashenlin will add 115 new stores in 2021 to obtain the qualification of dual-channel overall planning, covering 7 provinces and 31 prefecture-level citie.
As of January 21, 2022, a total of 119 stores have obtained dual-channel overall planning qualifications, covering a wide range, involving 1 municipality and 47 prefecture-level cities in 11 provinces including Hunan, Guangxi, Zhejiang, Henan, and Shandon.
In addition to being shortlisted for "dual-channel" designated retail pharmacies, leading chain companies are accelerating their staking, striving to enter the "Era of Ten Thousand Stores.
Among them, the common people have achieved this goal on June 26 this year, becoming the first private listed pharmacy chain enterprise in China with the number of stores exceeding "10,000 stores.
As of the end of March this year, the common people had 8,612 stores, that is to say, in less than three months, the number of new stores for the common people was as high as 1,388.According to the development momentum, the other three leading chain enterprises including Dashenlin, Yifeng Pharmacy, and Yixintang are also expected to achieve the goal of 10,000 stores this yea.
As of the end of March this year, Yifeng Pharmacy had 8,225 stores (a net increase of 416 stores in the first quarter), 8,469 Dashenlin stores (a net increase of 276 stores in the first quarter), and 8,809 Yixintang direct chain stores (a net increase of 276 stores in the first quarter.
Net addition of 249 stores in the quarter.
In general, at present, leading companies are accelerating mergers and acquisitions and expansion, and small and medium-sized pharmacies are accelerating their exi.
The integration pressure of the entire pharmaceutical retail market is intensifying, and the industry concentration will continue to increas.
The "Guiding Opinions on Promoting the High-Quality Development of the Drug Circulation Industry During the "14th Five-Year Plan" Period" pointed out that by 2025, 5-10 specialized pharmacies with a value of over 50 billion yuan will be cultivated, and the annual sales of the top 100 drug retail enterprises will account for The total retail market is more than 65%; the drug retail chain rate is close to 70.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyon.
